Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 2 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 5 analysts offering 12 month price targets for Summit Therapeutics Inc have a median target of 32.00, with a high estimate of 44.00 and a low estimate of 5.00. The median estimate represents a 73.72% increase from the last price of 18.42.
High | 138.9% | 44.00 |
Med | 73.7% | 32.00 |
Low | -72.9% | 5.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 18, 2025.
Average growth rate | -38.57% |
Average growth rate | +18.95% |
More ▼
Revenue history & estimates in USD
Average growth rate | -6.89% |
More ▼